We are live on ! Find out more
SLXP

SALIX PHARMACEUTICALS LTD DEL
SLXP

Delisted

SLXP was delisted on the 31st of March, 2015.

Back to rankings

1 hedge funds and large institutions have $6K invested in SALIX PHARMACEUTICALS LTD DEL in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CCS
Crosspoint Capital Strategies
California
+$6K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CCS
1
Crosspoint Capital Strategies
California
$6K +$6K +50 New

SLXP Hedge Fund Activity: Q4 2015 in Review

1 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q4 2015, worth a combined $6K.

Buyers outnumbered sellers: 1 fund opened new SLXP positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Crosspoint Capital Strategies, opening a new position worth an estimated $6K.

  • 1 institutional investor held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q4 2015, up from 0 in Q3 2015.
  • Funds reported $6K of SALIX PHARMACEUTICALS LTD DEL stock for Q4 2015.
  • 1 fund opened new SALIX PHARMACEUTICALS LTD DEL positions in Q4 2015 and 0 closed out, a net change of +1 holder.
  • The largest SALIX PHARMACEUTICALS LTD DEL buyer in Q4 2015 was Crosspoint Capital Strategies, an estimated $6K added.

Based on aggregated 13F filings for Q4 2015.